(Q34746864)

4 August 2017

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

1 reference

Huiying Rao

1

1 reference

4 August 2017

Lai Wei

2

1 reference

4 August 2017

Juan Carlos Lopez-Talavera

3

1 reference

4 August 2017

Jia Shang

4

1 reference

4 August 2017

Hong Chen

5

1 reference

4 August 2017

Jun Li

6

1 reference

4 August 2017

Qing Xie

7

1 reference

4 August 2017

Zhiliang Gao

8

1 reference

4 August 2017

Lei Wang

9

1 reference

4 August 2017

Jia Wei

10

1 reference

4 August 2017

Jianning Jiang

11

1 reference

4 August 2017

Yongtao Sun

12

1 reference

4 August 2017

Ruifeng Yang

13

1 reference

4 August 2017

Hong Li

14

1 reference

4 August 2017

Haiying Zhang

15

1 reference

4 August 2017

Zuojiong Gong

16

1 reference

4 August 2017

Lunli Zhang

17

1 reference

4 August 2017

Longfeng Zhao

18

1 reference

4 August 2017

Xiaoguang Dou

19

1 reference

4 August 2017

Junqi Niu

20

1 reference

4 August 2017

Hong You

21

1 reference

4 August 2017

Zhi Chen

22

1 reference

4 August 2017

Qin Ning

23

1 reference

4 August 2017

Guozhong Gong

24

1 reference

4 August 2017

Shuhuan Wu

25

1 reference

4 August 2017

Wei Ji

26

1 reference

4 August 2017

Qing Mao

27

1 reference

4 August 2017

Hong Tang

28

1 reference

4 August 2017

Shuchen Li

29

1 reference

4 August 2017

Shaofeng Wei

30

1 reference

4 August 2017

Jian Sun

31

1 reference

4 August 2017

Jiaji Jiang

32

1 reference

4 August 2017

Lungen Lu

33

1 reference

4 August 2017

Jidong Jia

34

1 reference

4 August 2017

Hui Zhuang

35

1 reference

4 August 2017

1 March 2014

1 reference

Journal of Gastroenterology and Hepatology

4 August 2017

1 reference

4 August 2017

29

1 reference

4 August 2017

545-553

1 reference

4 August 2017

3

1 reference

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Telaprevir for previously untreated chronic hepatitis C virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Boceprevir for untreated chronic HCV genotype 1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Review of HIV and HCV infection among drug users in China

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Management of patients co-infected with HBV and HCV.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Diagnosis, management, and treatment of hepatitis C: an update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Green tea consumption and liver disease: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Management of hepatocellular carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

A note on exact tests of Hardy-Weinberg equilibrium

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

7 July 2018

Blood banking in China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Low HCV replication levels in end-stage hepatitis C virus-related liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

7 July 2018

1 reference

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants

21 January 2018

1 reference

Changes in modes of hepatitis C infection acquisition and genotypes in southwest China

21 January 2018

1 reference

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.

21 January 2018

1 reference

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

21 January 2018

1 reference

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

21 January 2018

1 reference

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

21 January 2018

1 reference

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

21 January 2018

1 reference

Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Hepatitis C virus infections and genotypes in China

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272577

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

26 October 2018

1 reference

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24090188

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adoption of injection practices in heroin users in Guangxi Province, China

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24090188

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24090188

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/JGH.12398

1 reference

4 August 2017

1 reference

4 August 2017

1 reference